Rosner Jonathan Y, Gutierrez Megan, Dziadosz Margaret, Bennett Terri-Ann, Dolin Cara, Pham Amelie, Herbst Allyson, Lee Sarah, Roman Ashley S
a Division of Maternal Fetal Medicine, Department of OBGYN and Women's Health , Montefiore Medical Center, Albert Einstein College of Medicine , New York , NY , USA.
b Department of OBGYN , Saint Barnabas Medical Center , Livingston , NJ , USA.
J Matern Fetal Neonatal Med. 2019 Jan;32(2):188-192. doi: 10.1080/14767058.2017.1374363. Epub 2017 Sep 12.
Hypertensive disorders play a significant role in maternal morbidity and mortality. Limited data on prehypertension (preHTN) in pregnancy exist. We examine the risk of adverse outcomes in patients with preHTN in early (<20 weeks) versus late pregnancy (>20 weeks).
Retrospective cohort study of singleton gestations between August 2013 and June 2014. Patients were divided based on when they had the highest blood pressure in pregnancy, as defined per the Joint National Committee 7 (JNC-7). Groups were compared using χ, Fisher's exact, Student's t-test, and Mann-Whitney U test with p < .05 used as significance.
There were 125 control, 95 early preHTN, 136 late preHTN, and 21 chronic hypertension (CHTN). Early preHTN had an increased risk of pregnancy-related hypertension (PRH) (OR 12.26, p < .01) and composite adverse outcomes (OR 2.32, p < .01). Late preHTN had an increased risk for PRH (OR 4.39, p = .02) compared with normotensive and decreased risk for PRH (OR 0.26, p = .02), and composite adverse outcomes (OR 0.379, p = .04) compared with CHTN. Compared with late preHTN, early preHTN had more PRH (OR 2.85, p < .01), and composite adverse outcomes (OR 1.68, p = .04).
Early prehypertension increases the risk of adverse obstetrical outcomes. Other than an increased risk of PRH, patients with late prehypertension have outcomes similar to normotensive women.
高血压疾病在孕产妇发病和死亡中起着重要作用。关于孕期高血压前期(preHTN)的数据有限。我们研究了孕早期(<20周)与孕晚期(>20周)高血压前期患者出现不良结局的风险。
对2013年8月至2014年6月期间的单胎妊娠进行回顾性队列研究。根据美国国家联合委员会第7版(JNC - 7)的定义,将患者按孕期血压最高值出现的时间进行分组。使用χ²检验、Fisher精确检验、学生t检验和Mann - Whitney U检验对各组进行比较,以p < 0.05为有统计学意义。
有125例对照者、95例孕早期高血压前期患者、136例孕晚期高血压前期患者和21例慢性高血压(CHTN)患者。孕早期高血压前期患者发生妊娠相关高血压(PRH)的风险增加(OR = 12.26,p < 0.01)以及复合不良结局的风险增加(OR = 2.32,p < 0.01)。与血压正常者相比,孕晚期高血压前期患者发生PRH的风险增加(OR = 4.39,p = 0.02),而与慢性高血压患者相比,发生PRH的风险降低(OR = 0.26,p = 0.02),且复合不良结局的风险降低(OR = 0.379,p = 0.04)。与孕晚期高血压前期患者相比,孕早期高血压前期患者发生PRH更多(OR = 2.85,p < 0.01),且复合不良结局更多(OR = 1.68,p = 0.04)。
孕早期高血压前期会增加不良产科结局的风险。除了发生PRH的风险增加外,孕晚期高血压前期患者的结局与血压正常的女性相似。